<DOC>
	<DOC>NCT02089399</DOC>
	<brief_summary>The purpose of this study is to evaluate the pharmacokinetics profile and drug-drug interaction between amlodipine, olmesartan and rosuvastatin in healthy adult volunteers.</brief_summary>
	<brief_title>Pharmacokinetics and Drug Interaction Study Between Amlodipine,Olmesartan and Rosuvastatin in Healthy Adult Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Olmesartan</mesh_term>
	<mesh_term>Olmesartan Medoxomil</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Healthy male subjects aged 19 55 years A body mass index in the range 19 27 kg/m2 Willingness to participate during the entire study period Written informed consent after being fully informed about the study procedures Any past medical history of hepatic, renal, gastrointestinal, respiratory, endocrine, psychiatric, neurologic, haematooncologic or cardiovascular disease History of clinically significant drug hypersensitivity Use of medication within 7 days before the first dose Heavy drinker (&gt;140 g/week) Whole blood donation during 60 days before the study Judged not eligible for study participation by investigator</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>